Maryland-based company working to bring equitable healthcare access to cancer patients
COLUMBIA, Md., (May 27, 2026) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $225,000 State Small Business Credit Initiative (SSBCI) investment in 1104Health, a digital health company. This investment came through the organization’s Social Impact Funds.
“The current system has proven time and time again that more can be done to improve access for cancer patients, which is why we founded 1104Health,” said Rose Wang, CEO of 1104Health. "Oncologists want to do right by their patients — they need the tools and connections to make it possible. I know this firsthand. My husband passed away from melanoma after we learned too late that he had been eligible for a clinical trial at diagnosis. TEDCO's investment helps us keep building that infrastructure, so fewer families go through what mine did."
1104Health, located in Bethesda, Md, operates the Shared Care Network — a platform with the objective of connecting local oncologists and academic subspecialists to coordinate patient care while also working to identify clinical trial and treatment options for their patients. The platform is free for physicians and creates aligned incentives across the oncology ecosystem. The company aims to democratize access to cancer precision medicine to improve patient access and outcomes.
“TEDCO remains committed to supporting technology and life sciences innovation across industries,” said Jean-Luc Park, deputy chief investment officer & senior director of Social Impact Funds. “From medical innovations like the solution 1104Health developed to energy solutions and more—we are excited to be uplifting the innovation ecosystem.”
As one of three organizations that received funding from the Maryland SSBCI program, TEDCO was tasked with deploying the additional funds through four programs – the Venture Funds, Venture Capital Limited Partnership Equity program, Seeds Funds and the Social Impact Funds. With this funding, TEDCO offers more equity funding opportunities for early-stage technology and life sciences companies across the state, including areas with small, micro and Socially and Economically Disadvantaged Individual (SEDI) businesses.
“Innovators looking to not only expand their business, but enhance their research will find that Maryland is uniquely equipped to support these ambitions,” said TEDCO CEO, Troy LeMaile-Stovall. “After all, the state consistently ranks as the top in the nation for NIH research and development rewards with more than $1 billion in awards annually.”
For more information about the Social Impact Funds and how to apply, visit tedcomd.com.